3.50
price down icon4.89%   -0.18
after-market Dopo l'orario di chiusura: 3.43 -0.07 -2.00%
loading

Diamedica Therapeutics Inc Azioni (DMAC) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Research and Development
0.03%
3.676
3.677 3.272 2.543 3.618
Operating Income/Loss
1.83%
-5.741
-5.848 -5.157 -4.741 -5.521
Income/Loss From Continuing Operations Before Tax
0.10%
-5.144
-5.139 -4.464 -4.47 -5.265
Income Tax Expense/Benefit
68.18%
0.007
0.022 0.007 0.007 0.007
Income/Loss From Continuing Operations After Tax
0.19%
-5.151
-5.161 -4.471 -4.477 -5.272
Net Income/Loss
0.19%
-5.151
-5.161 -4.471 -4.477 -5.272
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,991%
37.96
1.8154 37.95 27.31 26.45
Basic Earnings Per Share
0.00%
-0.14
-0.14 -0.12 -0.16 -0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Capitalizzazione:     |  Volume (24 ore):